BURLINGTON, Mass., May 20, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (LMAT), a provider of peripheral vascular devices and implants, was ranked as #94 of the 100 best-performing publicly traded corporations based in Massachusetts by the Boston Globe.
"I was thrilled to receive the news that we were among the prestigious Boston Globe 100 top public businesses in Massachusetts," said George W. LeMaitre, Chairman and CEO. "It's an honor and a testament to the collective hard work put forward by our employees."
About the Globe 100 ranking methodology
The Boston Globe reports that it ranks Massachusetts-based public companies based on financial data from the four quarters ending closest to December 31, 2012, and for corresponding quarters a year earlier. To be eligible, the company must be traded publicly for the entire 2012 calendar year on the New York Stock Exchange, the Nasdaq or the American Stock Exchange and report revenue and profit for both 2011 and 2012. Companies are ranked on four criteria: return on average equity, one-year percentage change in revenue, one-year percentage change in profit margin and 2012 revenue.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart, including the Over-the-Wire LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt and XenoSure. Additional information can be found at http://www.lemaitre.com.
LeMaitre Vascular, Inc.